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SHARAD SETHUKUMARAN NAIR. The Effects of KV7 Channel Positive Modulation on 
Prefrontal Cortex Activity in Alcohol Dependent Mice. (Under the direction of PATRICK J. 
MULHOLLAND). 
Alcohol use disorder (AUD) is a chronic relapsing brain disease characterized by 
compulsive alcohol use, withdrawal symptoms, and adaptations in the reward 
neurocircuitry. Evidence from previous studies have demonstrated that voltage-dependent 
KV7 potassium channels are a novel target for reducing alcohol seeking and behaviors 
commonly associated with AUD. However, the underlying changes in KV7 channel 
expression and function following chronic alcohol exposure are still largely unknown. We 
believe that cortical interneurons play a crucial role in these behavioral and neural 
adaptations. We utilized immunofluorescent staining procedures to quantify alterations in 
KV7 channel colocalization with one of the primary interneuron subtypes, parvalbumin, 
found in the prelimbic cortex (PL) following the induction of ethanol dependence. In 
addition, we used fiber photometry to record calcium transients in the PL of C57BL/6J 
mice that express the genetically encoded calcium indicator, GCaMP6. Calcium transients 
were recorded in freely moving mice in an open field apparatus that were treated with 
ML213, a selective KV7.2/7.4 channel positive modulator, prior to and following the 
induction of ethanol dependence. Consistent with our previous findings, ML213 altered PL 
activity in ethanol dependent but not in non-dependent animals. Analysis of the calcium 
transients of C57BL/6J mice expressing GCaMP6s under the control of a human synapsin 
(hSyn) promoter revealed very slow calcium transients at a frequency of 0.075 ± 0.01 
events/second under basal conditions. However, the acute administration of ML213 
following the induction of ethanol dependence increased the frequency and reduced 
amplitude of these calcium transients. These effects were not replicated in non-dependent 
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nor in C57BL/6J mice expressing GCaMP6s selectively in glutamatergic neurons. These 
results provide evidence that the behavioral effects observed by KV7 channel positive 
modulation are influenced by possible adaptations on cortical interneurons. Our data 
suggest that KV7 channels are sensitized following ethanol dependence and allow for the 
coordination of interneuron activity in the PL.
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Alcohol use disorder (AUD) is a debilitating brain disease that affects millions of 
adults in the United States [1, 2]. Despite this, there are limited options for effective 
treatment of this disorder. Only three medications, disulfiram, naltrexone, and 
acamprosate have received U.S. Food and Drug Administration approval for primary 
use in the treatment of AUD [3]. However, other pharmacological treatments, primarily 
anticonvulsant medications, have shown beneficial effects in the reduction of alcohol 
seeking and withdrawal behaviors associated with AUD [4, 5]. As such, these are a 
promising class of pharmacological compounds that may lead to more efficacious 
treatment for individuals with AUD.  
AUD is characterized by the drive to seek and consume alcohol despite the known 
negative consequences; this drive is mediated partially by the prefrontal cortex of the 
brain. The prelimbic cortex (PL) is critical in the “top-down” regulation of behavior, 
functioning to control the initiation and inhibition of goal-directed behavior [6, 7]. 
Following chronic alcohol exposure, the functioning of the PL is impaired through 
changes in structure and neurotransmission [6, 8], resulting in various behavioral deficits 
in individuals suffering from AUD. The PL, as such, is a promising target for modulating 
and recovering these behavioral deficits following alcohol dependence. Rodent models 
of chronic ethanol exposure have shown impaired decision-making, increased ethanol 
consumption, and increased alcohol seeking behaviors similar to those observed in 
patients suffering from AUD [9-11]. Following chronic ethanol exposure, various novel 
pharmacological treatments have been tested to reduce overall consumption of ethanol.  
Use of anticonvulsants that target GABA (γ-aminobutyric acid) receptors, such as 
phenobarbital and diazepam, have been shown to reduce ethanol consumption in 
preclinical studies [3, 12, 13]. These treatments, however, cause an increase in alcohol 
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relapse in clinical trials [14]. Of the individuals seeking treatment for AUD, over 60% will 
relapse to heavy alcohol abuse [15], thus the need for more effective 
pharmacotherapeutics is of paramount importance. More recent pre-clinical studies 
have found a subset of anticonvulsant medications that target voltage-gated potassium 
(KV7) channels that have been shown to reduce both alcohol consumption and 
withdrawal symptoms [4, 5, 16]. These KV7 channel targeting drugs, as such, provide a 
novel option for AUD treatment without the adverse effects encountered with currently 
prescribed medications for AUD. Thus, exploring how KV7 channels in the PL function 
to regulate alcohol consumption is essential to understanding how KV7 channel-targeting 
drugs might be used as pharmacotherapeutics for AUD.  
Voltage dependent KV7 channels are located on glutamatergic pyramidal neurons 
and GABAergic interneurons and encoded by the Kcnq gene family. KV7 channels 
regulate action potential firing through a sub-threshold potassium ion (K+) current, known 
as M-current, and are composed of homomeric and heteromeric protein subunit 
assemblies (KV7.1-7.5) [17]. ML213, a KV7.2/7.4 positive modulator, has been shown to 
reduce alcohol consumption [4]. Our preliminary data show that ethanol dependent mice 
expressing the genetically encoded calcium indicator, GCaMP6s, under the human 
synapsin (hSyn) promoter and treated with ML213 exhibit robust oscillations in calcium 
transients in the PL [18]. Use of hSyn, a non-specific neuron promoter, results in 
GCaMP6s expression in both glutamatergic pyramidal neurons and GABAergic 
interneurons [19]. Interestingly, these  oscillations were not observed in Thy1-GCaMP6s 
transgenic mice (Thy1), which express GCaMP6s in cortical glutamatergic pyramidal 
neurons [20], nor were they present in non-dependent animals. The absence of this 
increased oscillatory activity in Thy1 mice suggests that it is a result of alterations of KV7 
channels on PL GABAergic interneurons in ethanol dependent animals. The key 
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requirement for this generation of oscillatory action is regulated and synchronized 
neuronal activity [21], an effect that has been reported to be under the control of KV7 
channels [22, 23]. This suggests that aberrant neuronal firing from populations of 
GABAergic interneurons is revealed in the presence of ML213 in ethanol dependent 
mice. Accordingly, we hypothesize that ethanol dependence alters KV7 channel 
expression and function in GABAergic interneurons in the PL. 
Pathology of AUD 
The progression of AUD may occur over an extended period of time, with early 
symptoms of the disorder being masked as casual or social drinking. The diagnostic and 
statistical manual of mental disorders, 5th edition, lists 11 diagnostic criteria for AUD. The 
severity of the disorder is based on the number of these criteria met over the same 12-
month period. Mild alcohol use disorder is indicated if 2 to 3 of the 11 criteria are met, 
moderate alcohol use disorder is indicated when 4 to 5 criteria are met, and severe alcohol 
use disorder is indicated if 6 or more of the criteria are met [24].  
Alcohol is a central nervous system depressant, and depending on the amount 
consumed, alcohol can act as an anti-convulsant, anxiolytic, muscle relaxant, sedative, or 
anesthetic. Low doses of alcohol (breath alcohol content [BAC] of ~0.03%) may have 
some positive symptoms including mood elevation and muscle relaxation, however, at 
higher doses (BAC ≥0.40%) alcohol may induce loss of consciousness, respiratory 
depression, or even death [25]. 
Although alcohol may not always be a direct cause of death or severe detriment to 
health, excessive alcohol use indirectly promotes a range of comorbid health ailments. 
Comorbid health issues that present with AUD can range in severity, however, the most 
common health conditions that present alongside AUD include: cardiovascular disease, 
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anemia, cirrhosis, cancer, seizures, depression, pancreatitis, and gout [26]. Long-term 
exposure to alcohol increases the risk of damage to most major organ systems [27]. The 
effects of low-to-moderate alcohol consumption (one to two alcoholic drinks per day) 
causes peripheral vasodilation and decreases the contractility of the heart, providing a 
mild reduction in blood pressure [27]. Those who indulge in low-to-moderate alcohol 
consumption may also confer a mild cardioprotective effect, resulting from the increase in 
high-density lipoprotein from consuming alcohol. However, individuals indulging in more 
than three drinks per day may experience cardiovascular issues ranging from left 
ventricular impairment and arrhythmia to heart failure [27]. Even a single exposure to 80+ 
proof liquor can produce atrial or ventricular arrhythmias in individuals who otherwise have 
no evidence of heart disease. Alcohol dependent individuals may also experience 
peripheral neuropathy, along with the previously mentioned comorbid health issues, as a 
result of alcohol toxicity [27]. In addition to the impaired functioning of the peripheral 
nervous system, alcohol dependence can cause major changes to the structure and 
function on the central nervous system. These changes include decreased white matter 
volumes and functional connectivity, as well as increased grey matter volumes and 
ventricular volume in the brain [28-30]. Modifications in brain structure and function 
following heavy alcohol drinking often lead to continued abuse and development of 
dependence in some individuals. 
Reward Circuitry of Alcohol Dependence 
The reward circuitry of the brain is often hijacked by substances of abuse, alcohol 
is no different [31]. The mesocorticolimbic dopamine pathways, which include structures 
like the ventral tegmental area (VTA), the nucleus accumbens (NAc) and the prefrontal 
cortex (PFC), play major roles in the positive reinforcing effects of alcohol. Additionally, 
the shell of the nucleus accumbens and central/medial amygdala appear to play major 
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roles in mediating the rewarding properties of abused drugs, as well as adaptive changes 
resulting from chronic drug exposure. This is a result of the nucleus accumbens and 
amygdala working together to engage the emotional aspects of the brain with the motor 
aspects of the brain. The inputs to and outputs from these pathways and brain regions are 
heavily modulated and regulated by the frontal cortex. Alcohol dependence diminishes the 
ability of the frontal cortex, through hypoactivation, to regulate these brain regions, 
increasing both impulsivity and compulsivity, which in turn propagates continued addiction 





Figure 1.1 – Changes in neural connectivity following the induction of alcohol dependence. The 
major regions of the brain that are impacted following the induction of alcohol dependence are 
the frontal cortex, amygdala, nucleus accumbens (NAc), and ventral tegmental area (VTA). 
Following dependence, the inhibitory control (green arrows) of the frontal cortex is diminished, 
allowing the dopaminergic signals (yellow arrows) projecting from the emotional and reward 
centers of the brain to have a larger influence outputs to the motor control (red arrows) of the 
brain. Adapted from Becker, 2018 [33]. 
 
Emotional and Reward Centers 
 Drug addiction is comprised of three stages: preoccupation/anticipation, 
binge/intoxication, and withdrawal/negative affect [32]. Impulsivity, or “a tendency toward 
rapid, unintended reaction to stimuli without regard for the negative consequences of 
these reactions” [31, 32], is primarily mediated by the preoccupation/anticipation stage of 
drug addiction [32], whereas compulsivity is primarily mediated by the latter stages. Early 
stages of drug addiction are characterized by functional changes in major regions of the 
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emotional and reward centers of the brain, including the amygdala, VTA, and the NAc [32, 
34-36]. Initial changes in neurotransmission in the central amygdala (CeA) are critical for 
the transition to alcohol dependence, these adaptations are primarily modulated by altered 
neuropeptide levels that alter inhibitory and excitatory transmission [34]. Dysregulation of 
the reward centers of the brain are mediated by a dysregulation of firing from the 
amygdala. The major reward centers of the brain affected following drug and alcohol 
exposure are the VTA and NAc, both of which enhance drug-dependent behaviors when 
dysregulated [31, 32]. Breakdown of normal functioning in these regions of the brain gives 
rise to negative affective and compulsive behaviors, that manifest as stress, anxiety, 
depression, and habitual drug seeking [31]. The dysregulation and breakdown of the 
functioning in these brain regions are closely tied to the reduced inhibitory control of the 
prefrontal cortex.  
Prefrontal Cortex 
 The prefrontal cortex plays a pivotal role in executive functioning and the top-down 
inhibitory control of goal-directed behaviors [6, 37]. Following exposure to drugs or alcohol, 
this inhibitory control is diminished [6, 7, 9, 11, 38], allowing for dysregulated action in the 
mesocorticolimbic system [39]. In both human and rodent models of alcohol dependence, 
marked changes in neurotransmission and brain structure have been observed in the 
prefrontal cortex. In vivo studies in Sprague-Dawley rats have produced reduced neuronal 
firing in the PFC when given intragastric administration of ethanol as compared to controls 
and saline condition [8]. Additionally, studies have shown differences in neurotransmission 
among varying strains of rats; strains that have a high preference for alcohol have 
increased levels of serotonin, and lower basal levels of glutamate and extracellular 
dopamine than do non/low-ethanol preferring rats [40-42]. Similar to rodent models, acute 
administration of alcohol in human studies has shown reductions in basal glutamate levels. 
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Human studies of chronic alcohol dependence have also shown deficits in behavioral 
functioning, similar to patients with lesions of the ventromedial prefrontal cortex [43]. 
Structural studies of alcohol dependent individuals also demonstrate reduced white matter 
volumes throughout the cortex, this reduction in cortical volume is not recovered after 6 
months of abstinence from alcohol [44-46]. These findings demonstrate the long-lasting 
impact of alcohol dependence even after protracted abstinence, particularly in the 
prefrontal cortex.  
 The functional and morphological changes of the prefrontal cortex observed under 
the influence of alcohol contribute to the cyclical nature of alcohol addiction and 
dependence. The subsequent dysregulated control of the prefrontal cortex propagates 
both impulsive and compulsive behaviors in alcohol dependent individuals. Among both 
animal and human models of alcohol dependence, there is parity in neuroadaptations 
involving neurotransmission. These changes in neurotransmission in the prefrontal cortex 
drive the functional and behavioral changes observed in the previously mentioned studies. 
As such, understanding how these neuroadaptations manifest following chronic alcohol 
exposure is vital to understanding and treating AUD. 
Glutamate and GABA 
 The activity of the prefrontal cortex is controlled and modulated by a number of 
neurotransmitters, namely glutamate and GABA [47]. Glutamatergic pyramidal neurons 
and GABAergic interneurons represent approximately 80% and 20% of the neuronal 
population in the prefrontal cortex, respectively [6]. Glutamate is the major excitatory 
neurotransmitter in the brain; activation of glutamate sensitive ionotropic receptors, AMPA 
(α-amino-3-hydroxy-methyl-4-isoxazoleproprionic acid) and NMDA (N-methyl-D-
aspartate), depolarize the post-synaptic membrane and allows for excitation and the 
generation of action potentials [47].  These receptors, referred to as type I receptors, are 
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typically located on dendrites and axons, away from the soma of the neuron. GABA 
receptors (type II receptors), on the other hand, are found on the axon initial segment or 
soma of neurons. GABA is the major inhibitory neurotransmitter in the brain; activation of 
GABAergic receptors, GABAA and GABAB receptors, clamp the membrane potential below 
the threshold needed for action potential firing [47, 48]. GABAergic interneurons are 
typically classified by the expression of different calcium binding proteins (parvalbumin, 
calbindin, calretinin, etc.) and neuropeptides (neuropeptide-Y, somatostatin, vasoactive 
intestinal peptide, etc.) [6]. The most common of these being parvalbumin- (PV) and 
somatostatin- (SST) containing interneurons in the prefrontal cortex [49]. The 
dysregulation of these systems of neurotransmission have been implicated in alcohol 
dependent individuals [48]. 
 Following exposure to chronic alcohol, both glutamatergic and GABAergic 
neurotransmission is altered. GABA neurotransmission, for example, is increased in the 
CeA [35, 36] and differences in the expression of genes that encode the GABAA receptor 
have been noted [48]. The most consistent change being a reduction in α1- and an 
increase in α4- subunits of the GABAA receptor [50]. Additionally, transmission of 
glutamate is suppressed immediately following exposure to alcohol through the inhibition 
of NMDA and AMPA ion currents [36, 51, 52]. Together, glutamate and GABA control 
neuronal activity and  brain function; therefore, altering the balance of either glutamate or 
GABA through disease or pharmacology can lead to over excitation (seizure, epilepsy, 
excitotoxicity) or inhibition (sleep, anesthesia, coma). However, through careful control of 
the activity of either or both glutamate and GABA, a number of pharmacotherapies have 
been developed to treat the symptoms and underlying disease of AUD. 
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Treatments for AUD 
 AUD is a complex disorder that can manifest as a multitude of symptoms and 
comorbid health conditions. As described below, there are currently only three FDA 
approved medications for the primary treatment of AUD: disulfiram, naltrexone, and 
acamprosate. These treatment options, however, are not efficacious in all patients 
suffering from the disorder. Over 60% of individuals seeking treatment for AUD relapse to 
heavy alcohol use even after treatment is administered. Recently, however, some 
anticonvulsant medications have been found to be effective inhibitors of alcohol seeking 
and consummatory behaviors in animal models and may be a promising novel treatment 
for AUD [53, 54]. 
Disulfiram 
Under normal metabolic conditions, alcohol is broken down, mostly in the liver, by 
alcohol dehydrogenase into acetaldehyde that is then broken down by aldehyde 
dehydrogenase into acetate. Disulfiram works by inhibiting aldehyde dehydrogenase, 
causing an accumulation of acetaldehyde following the consumption of alcohol. The 
accumulation of acetaldehyde is associated with many negative symptoms including 
headache, gastritis, nausea, and dizziness, thus discouraging patients from consuming 
alcohol to avoid these negative symptoms. Disulfiram is taken once daily and can aid in 
the management of selected patients who want to remain in a state of enforced sobriety 
so that supportive and psychotherapeutic treatment may be applied [55]. A major concern 
with Disulfiram is patient compliance, as the patient can simply refrain from taking the 
medication in order to avoid the negative consequences of the acetaldehyde accumulation 




Naltrexone, an opiate receptor antagonist, was originally developed as a long 
acting alternative treatment for opioid dependence, and was more recently approved for 
the treatment of alcohol dependence. Alcohol-induced increases in endogenous opioids 
are one of the primary mechanisms mediating the reinforcing properties of alcohol, thus 
blockade of opioid receptors, especially in the mesolimbic dopamine pathway are thought 
to be responsible for the moderate effectiveness of Naltrexone in reducing alcohol reward 
and craving [56]. Naltrexone can either be taken orally once daily or administered once 
every four weeks through an extended release injection and is indicated for the treatment 
of alcohol dependence in patients who can abstain from alcohol in an outpatient setting 
before the initiation of treatment. Although Naltrexone may be effective in treating AUD, it 
requires patients to be abstinent from alcohol for an extended period of time prior to the 
onset of treatment. Additionally, it has been suggested that a polymorphism (G118A) 
located on the µ-opioid receptor gene (OPRM1) may moderate the response to Naltrexone 
on blunting alcohol stimulation and craving [57, 58], thus reducing the patient population 
most suitable for treatment with Naltrexone.  
Acamprosate calcium 
 Acamprosate calcium is taken three times daily and is indicated for the 
maintenance of abstinence in alcohol dependent patients who are abstinent on treatment 
initiation. Acamprosate works to reduce the symptoms of protracted abstinence by 
counteracting alterations in the glutamatergic and GABAergic systems associated with 
chronic alcohol exposure and subsequent alcohol withdrawal. Specifically, Acamprosate 
calcium is thought to function as an antagonist at NMDA receptors and a positive allosteric 
modulator at GABAA receptors [52, 56, 59]. Although Acamprosate calcium is effective in 
abstinent patients, it works to reduce relapse and cravings associated with abstinence 
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from alcohol in alcohol dependent individuals and is most effective when used in 
conjunction with behavioral interventions to reduce drinking and maintain abstinence.  
Despite the availability of these treatments, all are met with limited efficacy and 
compliance, as such novel compounds and targets are necessary to treat the underlying 
causes of alcohol abuse disorders.  
Anticonvulsant medications 
 Anticonvulsants are one such novel treatment that have been previously examined 
to treat AUD. Multiple families of anticonvulsants have been tested in the treatment for 
alcohol dependence and withdrawal. The earliest anticonvulsant medications used were 
those targeting the GABAergic receptor system, such as diazepam and phenobarbital [12, 
13], which seemed promising in preclinical studies but were not efficacious in clinical trials, 
with patients relapsing at a staggeringly high rate after treatment and the treatments 
themselves having significant abuse liability. More recently, however, another family of 
anticonvulsants has shown promise in preclinical models that demonstrate reductions in  
alcohol seeking and consummatory behaviors. These medications act primarily as positive 
modulators of voltage-gated potassium channels.  
Potassium Channels 
Potassium ion (K+) channels play a critical role in the repolarization of action 
potentials, setting the resting membrane potential, and the regulation of firing frequency 
[60]. These channels locate in cell membranes and control the transport of K+ efflux and 
influx into the cell. Potassium selective channels are the largest class of mammalian ion 
channel proteins, with at least 79 genes in four distinct families [61]. Potassium channels 
can be organized into four major families: calcium-activated (KCa), inwardly-rectifying (Kir), 
tandem pore domain (K2P), and voltage-gated (KV) [60, 61].  
14 
 
Calcium-Activated Potassium Channels 
 Calcium-activated potassium channels are composed of six transmembrane 
domains and one pore-forming domain. These channels play a vital role in the regulation 
of intrinsic excitability and underlie the medium after-hyperpolarization (mAHP) following 
action potentials [61]. KCa channels are subdivided into five subfamilies (KCa1-5), which are 
encoded by KCNMA, KCNN, KCNT, and KCNU genes [62]. Subunits of KCa2 channels 
contain a calcium sensitive calmodulin-binding domain that senses changes in intracellular 
calcium concentration [61, 63]. The pore forming α subunit of KCa2.1, KCa2.2, and KCa2.3 
channels expressed in the central nervous system are encoded by the KCNN1-3 genes, 
respectively [61].  
These KCa2 channels have been implicated in alcohol exposure and dependent 
rodent models. Transcript levels of Kcnn3 in the NAc negatively correlated with voluntary 
drinking in both alcohol-naïve and alcohol exposed rodent models [53, 64], likewise 
reductions in Kcnn2 expression have also been observed in the prefrontal cortex and 
amygdala of alcohol dependent individuals [65]. Findings from these studies suggest that 
the changes in KCa2 channel expression, and subsequently KCNN, may underlie the onset 
of alcohol dependence. These channels, however, do not work independently; other 
families of potassium channels are also altered following exposure and dependence to 
drugs and alcohol. 
Inwardly-Rectifying Potassium Channels 
 The family of Kir channels plays a crucial role in the control of neuronal excitability 
and K+ homeostasis [66]. These inwardly-rectifying K+ channels are composed of two 
transmembrane domains, one P domain, and intracellular amino- and carboxy-termini 
[66]. Kir channels are subdivided into seven subfamilies (Kir1-7), each of which consists of 
multiple members (e.g. Kir2.1, Kir2.2, Kir2.3, etc.) that have conserved amino acid identity 
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across known mammalian species. Kir channel subunits are encoded by the KCNJ family 
of genes. These channels help establish resting membrane potential by mediating a small 
depolarizing K+ channel current at negative membrane potentials. Unlike other potassium 
channels, Kir channels are activated by ligand gated G-protein coupled receptors 
(GPCRs). In neurons of the central nervous system, G-protein coupled inwardly-rectifying 
K+ (GIRK) channels mediate inhibitory neurotransmitter response [67, 68], and are thought 
to play a key role in the maintenance of dopaminergic neurons [69, 70].  
 GIRK channels have been implicated in multiple neuropsychiatric diseases, 
including schizophrenia, depression, epilepsy, and drug and alcohol use disorders [71, 
72]. Specifically, studies have provided evidence to suggest that GIRK channels may play 
a role in the rewarding aspects of drug and alcohol consumption. In non-ethanol-
dependent C57BL/6J x DBA crossed (BXD) recombinant inbred (RI) mice, transcript levels 
of Kcnj3 (gene that encodes the GIRK1 subunit) in the NAc were positively correlated with 
voluntary alcohol drinking, and Kcnj2 (gene that encodes the GIRK2 subunit) transcript 
levels in the prefrontal cortex were negatively correlated with drinking [53]. Additionally, 
deletion of the Girk3 gene increased voluntary drinking in limited access models of ethanol 
consumption in mice, and overexpression of Girk3 in the VTA reduced drinking in wild-
type mice [73]. Changes in ethanol consumption in continuous access models of ethanol 
were not observed in Girk3 knockout mice [73], suggesting the influence of other systems 
in the development of addiction following continuous or chronic exposure to ethanol. 
Tandem Pore Domain Potassium Channels 
 K2P channels, often referred to as K+ leak channels, are composed of four 
transmembrane domains, two re-entrant pore P-forming loops, and intracellular amino- 
and carboxy-termini [74]. K2P channels are heteromeric protein subunit assemblies 
(K2P1-18, not including K2P8, K2P11, and K2P14), encoded by the KCNK family of genes 
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(KCNK1-18, not including KCNK8, KNCK11, and KCNK14, respectively) [74]. K2P 
channels pass K+ current in response to neurotransmitters, post-translational 
modifications, secondary messengers, temperature, and mechanical stress [74, 75]. 
These K+ leak channels are found ubiquitously in the nervous system and function to exert 
control over the excitability of neurons by shaping the duration, frequency and amplitude 
of action potentials [75]. However, not much is known about how these channels are 
modulated, if at all, following drug and alcohol addiction.  
Voltage-Gated Potassium Channels 
 KV channels, however, have been implicated in drug and alcohol use disorders [4, 
16, 61, 76]. These channels are tetramers formed by the assembly of six transmembrane 
domains and one P domain [71]. Helix domains S1-S4 form the K+ voltage sensor and 
domains S5-S6 form the pore [77, 78]. KV channels are subdivided into twelve subfamilies 
(KV1-12) according to the KV sequence homology classification, each of which consists of 
multiple subunits (e.g. KV2.1, KV2.2, KV2.3, etc.) [79]. Different KV channels have different 
kinetics and voltage dependence for activation [80]. Each of the subfamilies of KV channels 
are separated by functional classes: delayed rectifier, A-type potassium channel, outward-
rectifier, inward-rectifier, slowly activating, and modifier/silencer [53, 78]. Of these channel 
subtypes, delayed-rectifying KV7 channels have gained interest as a target for treating 
neuropsychiatric disorders, including AUD and depression [4, 53, 81]. 
Voltage-gated KV7 channels located on glutamatergic pyramidal neurons and 
GABAergic interneurons, are the targets of a subset of anticonvulsant medications. KV7 
channels generate a tonic subthreshold K+ current, referred to as M-current, which 
regulates the excitability of peripheral and central neurons. Kv7 channels are homomeric 
and heteromeric protein subunit assemblies (KV7.1-7.5), encoded by the KCNQ family of 
genes (KCNQ1-5, respectively) [61]. KV7.2-7.5 are primarily relegated to the brain, 
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whereas KV7.1 is primarily found in cardiac tissue and does not co-assemble with any of 
the other KV7 subunits [61]. KV7.2 and KV7.3 channels are found at several cellular pre- 
and post-synaptic locations, KV7.4 channels are expressed only in mesencephalic 
dopaminergic neurons at somatodendritic sites [82], and KV7.5 channels tend to cluster at 
postsynaptic membranes of GABAergic synapses [83, 84]. KV7.2/7.3 heteromeric 
channels form an M-current that acts as a brake on neuronal excitability [53]. KV7.5 
channels have high expression in the CA1 and CA3 regions of the hippocampus and 
contributes to the afterhyperpolarization of neurons in the CA3 region [85]. Studies have 
reported changes in KV7 channel expression and function following exposure to ethanol 
[4, 16, 53, 61]. Kcnq5 transcript expression, for example, has been negatively correlated 
with alcohol consumption in rodent models, the expression of Kcnq5 is also altered 
following chronic ethanol exposure [53]. This provides evidence that alcohol dependence-
mediated plasticity is either influenced by or influences KV7 channels, and as such is a 
novel target for treatment of alcohol dependence.  
Goals and Specific Aims 
Current treatments for AUD suffer from limited efficacy and compliance among 
patients. Limited understanding of the underlying mechanism of AUD has led to a 
shortage of effective pharmacological treatments for the disorder. Previous studies 
provide evidence that some anticonvulsant medications provide relief of several 
symptoms associated with alcohol withdrawal, as well as a reduction in alcohol 
consumption in individuals with AUD [54]. Most of these anticonvulsant medications, 
however, have only been effective in pre-clinical studies but not in clinical trials. As such, 
further study into the mechanism by which anticonvulsants act as a means of treating 
AUD is warranted. Recently, a subset of anticonvulsant medications that target KV7 
channels have been shown to reduce alcohol seeking and consummatory behaviors in 
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rodent models [4]. The primary goal of this study is to understand the neurobiological 
mechanism by which these novel treatments act to reduce alcohol seeking and 
consummatory behaviors. This will be examined using C57BL/6J mice to observe 
differences in KV7 channel expression, locomotion, and PL neuron activity following 
chronic ethanol exposure. 
As KV7 channels are primarily expressed on glutamatergic pyramidal neurons and 
GABAergic interneurons in the PL, we will primarily explore changes on these two neuron 
subtypes in this study. Our preliminary data suggests that cortical interneurons play an 
integral role in the functional changes observed in ethanol dependent mice under the 
influence of a KV7 channel positive modulator. As such, we hypothesize that ethanol 
dependence alters KV7 channel expression and function on GABAergic interneurons in 
the PL. This hypothesis will be tested by the following specific aims. Aim 1 will be 
discussed in Chapter 2, Aim 2 will be discussed in Chapter 3. 
Specific Aim 1. Test the hypothesis that ethanol dependence alters expression 
of KV7 channels on GABAergic interneurons. 
Specific Aim 2. Test the hypothesis that PL activity is altered by KV7 channel 
positive modulation following chronic ethanol exposure.  
The results of this study provide valuable information about how ethanol exposure and 
withdrawal alter KV7 channel expression and function in the PL, which have been identified 
as a key component in alcohol seeking and withdrawal behaviors. Understanding which 
subset of KV7 channels and on which subtype of cortical interneurons these changes are 




























KV7 channels are expressed on both glutamatergic pyramidal neurons and 
GABAergic interneurons. Our preliminary data indicates that ML213 induced oscillatory 
activity is only observed in dependent mice expressing GCaMP6s under the  non-
specific neuron promoter hSyn, and not in Thy1 transgenic mice. This suggests that KV7 
channel positive modulation results in coordinated and synchronous neural activity by 
GABAergic interneuron populations. In all in vitro models of gamma oscillations, GABA-
receptor mediated inhibition is required [21] suggesting that GABA-containing 
interneurons play a pivotal role in general oscillatory behavior. These data support our 
hypothesis that ethanol dependence alters KV7 channels expression or function on 
GABAergic interneurons.  
Materials and Methods 
Animals 
 Adult male C57BL/6J mice, at least 8 weeks of age and weighing ≥22g, were 
purchased from Jackson laboratory (Bar Harbor, ME). Animals were housed under a 
12:12 hour, reverse light:dark cycle with access to food (Harland Teklad Diet 2918) and 
water ad libitum.  
 All experiments were approved by the Medical University of South Carolina 
Institutional Animal Care and Use Committee and performed in accordance with the 
National Institute of Health guidelines for the use of animals in neuroscience research. 
Chronic Intermittent Ethanol Exposure 
Mice undergoing chronic intermittent ethanol (CIE) exposure were given 4 weeks 
of 16-hour ethanol vapor exposure (Mon – Fri; 5pm to 9am) interspersed with an 8-hour 
withdrawal period in their home cages (Fig. 2.1). Mice remained in their home cage on 
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Friday through Sunday for a 72-hour forced abstinence period. Food and water were 
provided ad libitum throughout CIE cycles. Immediately prior to daily ethanol exposure 
in vapor chambers, mice were given an intraperitoneal injection of 1.7 g/kg ethanol (8.3% 
w/v) and the alcohol dehydrogenase inhibitor pyrazole (1 mmol/kg) to stabilize blood 
ethanol concentrations (BEC). BECs were monitored weekly via blood plasma collected 
from orbital sinus blood samples captured in heparinized capillary tubes. At the time of 
collection, a target BEC of at least 175 mg/dL was maintained throughout the CIE cycles. 
 
Figure 2.1 – Model for Chronic Intermittent Ethanol (CIE) vapor exposure in mice. Mice receive 
4 weeks of 16-hour ethanol or air vapor exposure separated by an 8-hour withdrawal period for 
4 consecutive days. Mice will remain in their home cage on Saturday and Sunday. Food and water 
were available ad libitum throughout CIE cycles. BECs maintained at ≥175 mg/dL. 
 
Tissue Collection 
Mice were anesthetized using urethane (1.5 g/kg) and  perfused transcardially 
with 1x phosphate buffered saline (PBS; pH 7.4) followed by 4% paraformaldehyde 
(PFA; in 1x PBS). Following perfusions, whole brains were extracted and postfixed in 
4% PFA in 1x PBS overnight at 4°C, then transferred to a solution of 1x PBS and stored 
at 4°C. Forty µm sections of PFC were collected using a Leica VT 1000S Vibratome 
(Wetzlar, Germany). Sections were then stored in a 0.1% sodium azide solution in 1x 




Sections of PFC were immunostained for the presence of KV7.2 channels and 
PV-containing (PV+) GABAergic interneurons. Antigen retrieval with 10 mM sodium 
citrate buffer, pH 8.5, was carried out prior to immunostaining. Specifically, brain 
sections were washed with 1x PBS, pH 7.4, three times for 5 minutes then transferred 
to a solution of 10 mM sodium citrate buffer, preheated to 80°C in a dry block heater, 
for 30 minutes. The sections are retained in the sodium citrate solution and allowed to 
cool to room temperature, after which the sections are washed in 1x PBS three times 
for 5 minutes.  
Following sodium citrate antigen retrieval, slides are washed in 1x PBS six times 
for 5 minutes, then treated with 50% MeOH in 1x PBS for 30 minutes, and 1% H2O2 in 
1x PBS for 15 minutes. The sections are then washed again in 1x PBS five times for 1 
minute. Following which the sections were permeabilized with 0.4% Triton-X in 1x PBS 
for 30 minutes, then blocked with 10% normal donkey normal serum for 1 hour and 
allowed to incubate with primary antibody overnight: rabbit anti-KCNQ2 (1:250, Thermo, 
PA1-929) and goat anti-parvalbumin (1:500, Swant, PVG-213). The following day, the 
sections are once again washed with 1x PBS ten times for 1 minute, then left to incubate 
in the secondary incubation for 2 hours. The secondary incubation consisted of donkey 
anti-rabbit Rhodamine Red-X (1:250, Jackson Immuno, 711-295-152), donkey anti-goat 
Alexa Fluor 488 (1:250, Jackson Immuno, 705-545-003), and donkey anti-rat Alexa 
Fluor 405 (1:250, Abcam, ab175670) secondary antibodies. Following the secondary 
incubation, sections were washed in 1x PBC three times for 10 minutes. After which, 




Z-stack images from immunostained slides (n=4 mice/group, 3 PL slices per 
mouse) were obtained using 20x- and 63x objectives on a confocal microscope (Carl 
Zeiss LSM 880). Images obtained using the 20x objective were further refined through 
deconvolution algorithms using AutoQuant X3 prior to analysis. 63x images were 
collected using an Airyscan super-resolution detector. The collected images were then 
analyzed using Imaris image analysis software. Expression levels of KV7.2 channels in 
widefield (20x) images of the PL were determined by optical density of fluorescent 
expression above an automatic threshold generated by Imaris. The amount of KV7.2 
channel fluorescence (AU) that remained above this automatic threshold was then 
exported and analyzed. The amount of colocalization of KV7.2 channels with PV+ 
interneurons was determined by utilizing the “spots” function on Imaris to map out 
fluorescent clusters of KV7.2 channels, providing a measure of individual channels or 
groups of channels. After creating a mask for both PV+ interneuron and KV7.2 channel 
fluorescence, an automatic fluorescence threshold, generated by Imaris, was used to 
determine which “spots” of KV7.2 channels colocalized with individual PV+ interneurons 
in 63x images. The number of “spots” that colocalized per voxel of PV+ interneuron 
(fluorescence/µm3) was then obtained for analysis. 
Statistics 
 For data consisting of multiple groups, repeated measures analysis of variance 






Effects of Chronic Ethanol Exposure on Cortical Interneuron Expression 
 KV7 channels are located on both cortical glutamatergic pyramidal neurons and 
GABAergic interneurons, as such the behavioral changes resulting from KV7 channel 
positive modulation in ethanol dependent rodents may underlie changes on one of 
these neuron populations. There is evidence suggesting that KV7 channels regulate 
interneuron properties in a cell-type specific manner [86, 87]. Deletion of KV7.2/7.3 
heteromeric channels results in changes in neuron firing on PV+ but not SST+ 
interneuron populations [86]. This suggests that KV7 may be working through PV+ 
interneurons to alter PFC function. To test whether the observed behavioral changes 
following the induction of ethanol dependence under the influence of KV7.2/7.4 positive 
modulator [4] were the result of neuroadaptations linked to KV7.2 channel expression 
on PV+ interneuron populations, we utilized immunohistochemical procedures.  
 To induce ethanol dependence in C57BL/6J mice, we used a chronic intermittent 
ethanol vapor inhalation exposure model [10]. Two groups of C57BL/6J mice were 
utilized, a control group that was only exposed to air (AIR) and an experimental group 
that was exposed to ethanol (CIE, Fig. 2.1). Following four weeks of either AIR or CIE, 
PFC tissue was collected for immunohistochemical treatment and analysis. Expression 
of KV7.2 channels did not differ between the control and experimental groups in slices 
of PL (t[24]=0.4831, P=0.6334). Likewise, the expression of KV7.2 channels that 
colocalized in PV+ interneurons did not differ between the two groups (t[26]=0.5929, 
P=0.5583). These findings suggest that overall expression of KV7.2 channels in the PL 



















































Figure 2.2 – Colocalization of KV7.2 channels with parvalbumin-containing interneurons. 
Fluorescence of KCNQ2 was analyzed in PL slices of air-exposed and CIE-exposed adult male 
C57BL/6J mice. (a) Expression of KV7.2 channels in slices of PL and in PV+ interneurons were 
collected using 20x- and 63x- objectives, respectively, on a confocal microscope. No significant 
difference in (b) total KV7.2 expression (P=0.996) nor in (c) KV7.2 expression on PV+ interneurons 






Previous studies have shown that modulation of KV7 channels impacts the firing 
pattern of PV+ interneuron populations [86]. As such, the behavioral changes observed in 
ethanol dependent animals [4, 9, 11] could partially be influenced by changes found in 
PV+ interneurons. Using immunostaining of KV7.2 and parvalbumin, CIE did not reduce 
the expression of KV7.2 channels in the PL (Fig 2.2C) nor in PV+ interneuron populations 
in the PL (Fig 2.2D). There are multiple caveats to this method of determining channel 
expression, however, including the inability to distinguish between intracellular and 
surface level expression of KV7.2 channels on PV+ interneurons, the inability to address 
functional changes that may be occurring following CIE exposure, and the lack of insight 
into alterations in other neuron and KV7 channel subtypes. 
Colocalization analysis, like the analysis performed here, is unable to distinguish 
between surface level and intracellular protein expression. As trafficking of channels to 
and from the cell membrane plays a vital role in the functional activity of proteins and 
channels, without properly identifying surface level expression of these proteins, we are 
unable to accurately portray structural changes that underlie any observed function shifts. 
Future studies that elucidate surface level expression of KV7 channels will be needed to 
better understand ethanol-dependent changes in KV7 channel expression in the PL. 
Additionally, immunostaining procedures lack the ability to provide insight into functional 
changes resulting from ethanol dependence in the PL. Utilizing techniques such as fiber 
photometry (described below) and electrophysiology in the future will be vital in mapping 
functional and connectivity changes resulting from KV7 channel alterations following 
exposure and dependence to ethanol. 
Lastly, there are a wide array of KV7 channel and neuron subtypes that populate 
the prefrontal cortex. The observed functional and behavioral changes cannot be 
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attributed to a singular KV7 channel or neuron subtype. Previous studies have already 
shown evidence that other KV7 channels besides KV7.2 are altered following exposure to 
ethanol. The expression of Kcnq5 transcripts, for example, have been noted to be 
significantly altered in ethanol dependent BXD RI strains of mice [53]. This highlights the 
necessity to elucidate expression changes in other KV7 channel subtypes. Likewise, 
changes in KV7 channel expression on other interneuron or pyramidal neurons may also 
contribute to the functional and behavioral changes mentioned previously. As such, 
additional study into the change of KV7 channel expression on additional neuron subtypes 
is warranted. Despite these limitations, we next examined the activity of PL neurons using 
fiber photometry and determined how KV7 channel modulation affected neuron activity in 















CHAPTER 3: PL ACTIVITY IS ALTERED BY KV7 CHANNEL POSITIVE MODULATION 






















Kcnq5 transcript expression in the PFC of BXD RI strains of mice has been 
negatively correlated with voluntary ethanol drinking and is altered by CIE exposure [53]. 
This suggests that ethanol exposure and subsequent dependence alters KV7 channel 
expression in PL neuron populations. KV7 channel positive modulating treatments have 
shown both a significant decrease in ethanol consumption [4, 16], as well as indications 
of coordinated and synchronous neural activity in dependent animals. In the mouse 
brain, some KV7 channels are localized to key sites for the control of neuronal network 
oscillations and synchronization [23], suggesting that they play a key role in the generation 
of oscillatory behavior. This coordinated and synchronous activity likely manifests as 
oscillations in calcium transients of mice infected with hSyn virus. These oscillations are 
not, however, observed in non-dependent mice, nor in Thy1 transgenic mice. hSyn is a 
non-specific neuron promoter that will express the genetically encoded calcium 
indicator, GCaMP6s, in both glutamatergic pyramidal neuron and GABAergic 
interneuron populations; whereas Thy1 transgenic mice express GCaMP6s only in 
glutamatergic pyramidal neuron populations [19, 88, 89]. These results support our 
hypothesis that KV7 activity in cortical interneurons is modulated by ethanol dependence. 
For this aim, we built on these data and performed fiber photometry experiments to 
determine functional changes occurring in PL neuron populations resulting from ethanol 
exposure and subsequent dependence, as well as KV7 channel modulation. 
Materials and Methods 
Animals 
 Adult male C57BL/6J mice, at least 8 weeks of age and weighing ≥22g, were 
purchased from Jackson laboratory (Bar Harbor, ME). Animals were housed under a 
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12:12 hour, reverse light:dark cycle with access to food (Harland Teklad Diet 2918) and 
water ad libitum.  
 All experiments were approved by the Medical University of South Carolina 
Institutional Animal Care and Use Committee and performed in accordance with the 
National Institute of Health guidelines for the use of animals in neuroscience research. 
Viral and Fiber Implants 
 Mice were separated into two groups that were infused with either AAV1-hSyn-
GCaMP6s-WPRE (n=4) or AAV1-CaMKII-GCaMP6f-WPRE (n=4) virus into the PL. 
Anesthesia was induced using 1-2% isoflurane, inhaled, prior to and during stereotaxic 
surgery. Breathing rate in mice was monitored throughout the surgery to ensure that 
anesthesia was maintained. Mice were given a unilateral injection of 200nl of either 
AAV1-hSyn-GCaMP6s-WPRE or AAV1-CaMKII-GCaMP6f-WPRE virus in the PL using 
the following coordinates: AP: +1.7mm; ML: ±0.4mm; DV: -2.35mm from bregma at the 
skull surface. A 400-micron diameter multimodal fiber was then chronically implanted 
with the tip of the fiber at the following coordinates: AP: +1.7mm; ML: ±0.4mm; DV: -
2.25mm from bregma at the skull surface. Standard post-operative care was maintained 
for 3 days following surgery to ensure survival and wellbeing of the mice. Mice were then 
given 4-6 weeks of recovery in their home cage following the fiber implant to allow for 
proper viral expression prior to testing.  
Fiber Photometry 
Fiber photometry allows for temporally precise in vivo measurements of neural 
activity using optic fibers to both excite and record from genetically encoded calcium 
indicator (GECI) [90], GCaMP6, in the PL. Our photometry system utilizes 470 and 405nm 
wavelength LEDs (Thorlabs; Newton, NJ) that are coupled, for GECI and control 
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isosbestic excitation, respectively, into one path via dichroic mirrors and directed to the 
region of interest, the PL, through a fiber optic patch cable. At the time of recording this 
patch cable is connected to a chronically implanted ferrule on the mouse. The LED 
intensity at the interface between the fiber tip and the animal was maintained at 3 µW 
across all recordings. The power output of the system was tested prior to each day of 
recording using an optical power meter (PM20, Thorlabs; Newton, NJ). A real-time signal 
processor (RZ5P, Tucker-Davis Technologies; Alachua, FL), running Synapse software , 
modulated each laser’s output. The outputs from each of the LEDs were projected onto a 
photodetector (Newport; Irvine, CA) which were later demodulated for analysis. Signals 
from the 470 and 405nm wavelength LEDs were collected at sampling frequencies of 211 
and 531Hz, respectively.  
Analyses of fiber traces were performed using custom-written functions in 
MATLAB. The calcium signals recorded from the 470 and 405nm wavelength LEDs were 
first fitted to a polynomial versus time and then subtracted from one another to calculate 
the ΔF/F time series. This provides a normalized calcium signal in the region of interest 
during behavioral testing. Additional analyses in MATLAB were used to determine the 
frequency of events, mean inter-event interval, and mean event of the normalized calcium 
signal. Events were determined using a FindPeaks function in MATLAB, we utilized a 
threshold known as the median absolute deviation (MAD) to distinguish events. The MAD 
is a robust measure of variability of a sample of quantitative data. All normalized values in 
the calcium transients that exceeded double the MAD threshold were considered events. 
MAD values obtained from pre-CIE vehicle recordings of each animal were used to 
analyze event data across all drug doses to maintain consistency among the analyses. 
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Open Field Behavioral Assay 
Locomotion and calcium transients were analyzed in an open field apparatus pre- 
and post-CIE exposure. Mice were initially given an intraperitoneal injection of saline 
(0.30 ml) 15 minutes prior to being habituated to the open field apparatus (16in. x 15in. 
x 15in.). Following this 15-minute delay, mice were free to explore the apparatus for 15 
minutes. The following day, mice were given an intraperitoneal injection of vehicle (10% 
tween80 v/v saline) 15 minutes prior to testing, connected to the fiber photometry 
system, and then placed back in their home cage. Following the 15-minute delay, 
individual mice were placed back in the open field apparatus where they were free to 
roam and explore for 30 minutes without any external stimulation. After testing, mice 
were removed from the apparatus, disconnected from the fiber photometry system and 
returned to their home cage. During the following 3 days, mice underwent similar 
procedures as the vehicle test, however, they instead received intraperitoneal injections 
of  KV7.2/7.4 channel opener, ML213 (2.5, 5.0, or 7.5 mg/kg), in a counterbalanced 
design. These procedures, including habituation, vehicle, and drug testing were 
repeated 10 days following the last CIE exposure. Locomotion in the open field 
apparatus was tracked via live camera recordings and analyzed using Ethovision XT14. 






Figure 3.1 – Model for fiber photometry in an open field apparatus. Ferrules containing 
multimodal fibers were implanted in the PL of C57BL/6J mice that were injected with an AAV 
containing a specific neuron promoter expressing GCaMP. Implanted ferrules are then connected 
to a fiber photometry system emitting LED light through multimodal fibers. Two wavelengths of 
LED light excite the GCaMP located in the PL and the resulting fluorescence is then sent to a 
photoreceiver which is then processed and visualized on a computer. A 405nm LED is used to 
detect noise or movement artifacts from the fiber, and a 470nm LED is used to detect the GCaMP 
signal. 
 
Chronic Intermittent Ethanol Exposure 
Mice undergoing CIE exposure were given 4 weeks of 16-hour ethanol vapor 
exposure (Mon – Fri; 5pm to 9am) interspersed with an 8-hour withdrawal period in their 
home cages (Fig. 2.1). Mice remained in their home cage on Friday through Sunday for 
a 72-hour forced abstinence period. Food and water were provided ad libitum throughout 
CIE cycles. Immediately prior to daily ethanol exposure in vapor chambers, mice were 
given an intraperitoneal injection of 1.7 g/kg ethanol (8.3% w/v) and the alcohol 
dehydrogenase inhibitor pyrazole (1 mmol/kg) to stabilize BEC. BECs were monitored 
weekly via blood plasma collected from orbital sinus blood samples captured in 
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heparinized capillary tubes. At the time of collection, a target BEC of at least 175 mg/dL 
was maintained throughout the CIE cycles. 
Tissue Collection 
Mice were anesthetized using urethane (1.5 g/kg) and  perfused transcardially 
with 1x PBS (pH 7.4) followed by 4% PFA (in 1x PBS). Following perfusions, whole 
brains were extracted and postfixed in 4% PFA in 1x PBS overnight at 4°C, then 
transferred to a solution of 1x PBS and stored at 4°C. Forty µm sections of the prefrontal 
cortex were collected using a Leica VT 1000S Vibratome (Wetzlar, Germany). Sections 
were then stored in a 0.1% sodium azide solution in 1x PBS (pH 7.4), at 4°C until 
mounted on SuperFrost Plus microscopy slides (Fisher Scientific, Waltham, MA) to verify 





Figure 3.2 – Viral expression of GCaMP and placement of chronically implanted fiber probes. 
Example histology of probe placement and viral expression. Any animal whose probe and GCaMP 
expression were not located in the PL was excluded from the study. Adapted from Paxinos and 
Franklin’s the Mouse Brain in Stereotaxic Coordinates, 2012 [91].  
 
Statistics 
 For data consisting of multiple groups, repeated measures analysis of variance 
(ANOVA) was used; single comparisons were analyzed using a t-test assuming equal 





Effect of KV7 positive modulation on locomotion 
 KV7 positive modulation reduces alcohol seeking and consummatory behaviors in 
rodent models of alcohol addiction [4]. However, it is unclear whether this reduced 
motivation to engage in alcohol seeking behaviors is due to reduced locomotion, KV7-
dependent changes in modulation of PL activity, or a mixture of both. Previous studies 
have found that ML213, a KV7.2/7.4 channel positive modulator, does significantly reduce 
the overall locomotion of rats at doses of 5 mg/kg or higher [4]. As such, finding a dose of 
KV7 channel positive modulating drug that does not significantly reduce locomotor activity 
while still retaining the positive behavioral effects is vital.  
 We utilized the CIE model, previously described (Fig. 2.1) [10], to test differences 
in locomotion prior to and following the induction of alcohol dependence. Adult male 
C57BL/6J mice were placed in an open field apparatus where they could freely roam for 
30 minutes following a 15-minute pre-injection of vehicle (10% Tween80 v/v saline) or a 
pseudo-randomized dose of ML213 (2.5, 5.0, or 7.5 mg/kg) across four days of testing. 
Locomotion in the open field apparatus was tracked live using a camera and analyzed 
using Ethovision XT14. Prior to the induction of ethanol dependence, a significant 
reduction in locomotion during the 30-minute testing period was observed in mice treated 
with ML213 as compared to vehicle (F[3,84]=18.02, P<0.0001) (Fig 3.3A). Locomotion 
was significantly reduced at doses of ML213 ≥5.0 mg/kg, with the reduction of locomotion 
following a dose-dependent manner in non-dependent animals. Locomotion was again 
tracked and analyzed after a 10-day withdrawal following the induction of ethanol 
dependence in the same open field apparatus (F[3,72]=4.079, P=0.0098) (Fig 3.3B). 
Consistent with results prior to CIE exposure, there is a significant reduction in the total 
distance travelled at 7.5 mg/kg of ML213 when compared to vehicle. However, distance 
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travelled was not significantly reduced by 5.0 mg/kg of ML213 post-CIE. Interestingly, 
there was a significant reduction in the total distance travelled pre- and post-CIE at the 
vehicle doses (t[55]=2.046, P=0.0456), suggesting that CIE exposure alone may alter 
locomotor behavior in mice. 
Effect of KV7 positive modulation on neuronal activity 
During the open field behavior that tracked locomotor activity, two cohorts of mice 
were connected to a fiber system to collect and store calcium transients during the 
behavior. These two cohorts of adult male C57BL/6J mice were injected with an adeno-
associated virus (AAV) expressing GCaMP6f under glutamatergic neuron specific 
promoter CaMKII or general neuron promoter hSyn into the PL. These mice were tested 
prior to and following the induction of ethanol dependence as described previously.  
In animals expressing GCaMP6f under the control of the CaMKII promoter 
containing virus, there were no changes in calcium dynamics between the pre- and post-
CIE recordings, nor did ML213 affect any of the variables measured (i.e., event frequency, 
or amplitude; Fig 3.4A). There was also no main effect of drug or CIE exposure, nor an 
interaction of drug and CIE exposure in any of these measured variables in this cohort 
(event frequency: F[3,9]=0.4946, P=0.6949; amplitude: F[3,9]=0.8125, P=0.5185). 
In contrast to the data collected under the effect of the CaMKII promoter, ML213 
altered the frequency and amplitude of events in dependent mice expressing GCaMP6s 
under the control of a hSyn promoter. There was a significant interaction in the frequency 
of events and the average amplitude of the calcium transients between CIE exposure and 
drug (event frequency: F[3,9]=4.182, P=0.0413; amplitude: F[3,9]=4.348, P=0.0374; Fig 
3.4B). These significant changes were observed at the highest dose of ML213 (7.5 
mg/kg), however, a shift in the properties of calcium transients begins to emerge following 
administration of even the lowest dose of ML213 following ethanol dependence. While 
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there were no significant differences noted in the CaMKII promoter cohort, significant 
differences in event frequency at 7.5 mg/kg of ML213 following the induction ethanol 
dependence were evident in mice expressing GCaMP6s under the hSyn promoter. This 
provides evidence that KV7 channels may be sensitized on interneurons following ethanol 


















Figure 3.3 – Locomotion prior to and following the induction of ethanol dependence at varying 
doses of ML213. Locomotion during 30-minute test sessions of the open field behavioral assay 
was tracked using live camera recordings and analyzed with Ethovision XT14. C57BL/6J mice were 
injected with pseudo-randomized doses of ML213 (0, 2.5, 5.0, or 7.5 mg/kg, i.p.) 15 minutes prior 
to behavioral testing. (a) Prior to the induction of ethanol dependence (n=33), a  significant 
reduction in overall locomotion was noted at 5.0 and 7.5 mg/kg of ML213. (b) Following the 
induction of ethanol dependence (n=25), a significant reduction of locomotion was only noted at 
a dose of 7.5 mg/kg of ML213. *indicates P<0.05, *** P<0.001, **** P<0.0001. 
 
Figure 3.4 – Analysis of calcium transients in hSyn and CaMKII promoter expressing C57BL/6J 
mice. Average event frequency, and event amplitude of calcium transients before and after the 
induction of ethanol dependence through CIE exposure under the effect of ML213 (0-7.5 mg/kg, 
i.p.) in cohorts of adult male C57BL/6J mice expressing (a) CaMKII-promoter containing virus (n=4) 






Figure 3.5 – Representative traces of GCaMP6 transients. Representative traces of GCaMP6 
transients recorded from PL neurons of mice infected with (a) AAV1-CaMKII-GCaMP6f-WPRE and 
(b) AAV1-hSyn-GCaMP6s-WPRE prior to and following the induction of ethanol dependence under 




 Following the development of alcohol dependence, a number of studies have 
provided evidence that neuroadaptations occur in the prefrontal cortex [6, 9, 11, 38, 92], 
we sought to illuminate these changes in the PL following ethanol dependence. Utilizing 
fiber photometry, we examined changes in neural function in the PL. Prior to the induction 
of ethanol dependence in both the CaMKII and hSyn cohorts of animals, ML2123 did not 
affect calcium dynamics. Following the induction of ethanol dependence, however, a 
separation begins to emerge between vehicle and the highest dose of ML213 in ethanol 
dependent mice, compared to pre-CIE at the same dose only in mice expressing 
GCaMP6s under the hSyn promoter. There is a significant increase in the event frequency 
and amplitude following ethanol exposure at 7.5 mg/kg of ML213. The increased event 
frequency and reduced amplitude in calcium transients implies that ethanol dependence 
increases the ability of KV7 channel positive modulation to alter PL activity in this 
subpopulation of neurons. This difference is not evident in the CaMKII promoter-containing 
virus, suggesting that these changes are occurring outside of the control of glutamatergic 
neurons within the PL. This provides functional evidence that the observed behavioral 
changes following ethanol exposure under the effect of KV7 channel positive modulation 
are likely the result of changes in GABAergic interneurons. The caveat to this approach is 
that the specific subtype of GABAergic neuron responsible for these changes is not clear 
as hSyn is a nonspecific neuron promoter.   
During the 30-minute recording sessions in the open field apparatus, the 
locomotion of mice was significantly reduced at higher doses of ML213 in both pre- and 
post-CIE groups. Consistent with previous reports, these data suggest that the KV7.2/7.4 
positive modulator induces a reduction in locomotor activity at doses equal to or greater 
than 5.0 mg/kg [4]. Providing evidence that treatments of ML213 may be utilized with 
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doses lower than 5.0 mg/kg to aid in reducing alcohol seeking and consummatory 
behaviors in rodent models of ethanol dependence. Although not fully explored here, there 
appears to be a tolerance to the sedative effects of ML213 as a result of ethanol 
dependence, which may be an interesting area for additional study. These locomotor 
findings are not explained by the analysis of calcium transients collected from the fiber 
traces of these same animals.  
Interestingly, in rat models of alcohol exposure, significant reductions in locomotor 
activity are not observed alcohol-naïve rats. Reductions in locomotor activity begin to 
appear in rats who have undergone protracted abstinence from alcohol following 
administration of ML213 at doses of 5 mg/kg and higher [4]. This suggests that there is 
some parity in locomotor activity between rat and mouse models of alcohol exposure, as 
we observed locomotor deficiencies at 7.5 mg/kg in ethanol dependent mice. Unlike in 
rats, though, we observed a significant decrease in locomotor activity in non-dependent 
animals. This may be the result of the different models of alcohol exposure used within 
these models. The McGuier, et. al. study utilized 8 weeks of intermittent access to alcohol 
as method voluntary drinking model whereas we used chronic intermittent ethanol 
inhalation in vapor chambers as our exposure method. Further study into this change in 
locomotor activity would provide insight into whether there is discrepancy among species 




























Previous studies have shown strong evidence for the modulation of both 
glutamatergic and GABAergic neuron populations following the exposure to alcohol [6, 93-
98]. Likewise, we know that KV7 channels are primarily found on glutamatergic pyramidal 
neurons as well as GABAergic interneuron populations, and play a major role in inhibitory 
action of neural activity [22, 23, 53, 85, 86, 99, 100]. Following the induction of alcohol 
dependence, the inhibitory control of the frontal cortex is diminished (Fig 1.1), as such 
positive modulation of KV7 channels in the prefrontal cortex appears to be a novel 
treatment option in recovering the behavioral deficiencies linked with AUD. Previous 
studies have shown this to be the case, positive modulation of KV7 channels produces 
reduced alcohol seeking and consummatory behaviors in rodent models [4, 16]. We 
utilized immunohistochemistry, behavioral analysis, and fiber photometry to better 
understand how the modulation of KV7 channels alter neuron function to produce these 
behavioral phenotypes in rodent models of dependence.  
Through these studies we show that KV7.2 expression remains unchanged in the 
PL following exposure to chronic ethanol, both in total expression and in expression on 
PV+ interneurons. These data consider both intracellular and surface level expression of 
KV7.2 channels together, without distinguishing between the two, as such it is hard to 
determine whether channel trafficking of these channels on PV+ interneurons are 
responsible for previously noted changes through ethanol exposure. To fully understand 
how the trafficking of KV7 channels is affected following ethanol dependence, additional 
studies using western blots, bis(sulfosuccinimidyl) subterate (BS3)-cross linking, and 
electrophysiology are required in addition to immunostaining with the various other KV7 
channel and neuron subtypes that are found in the PL. 
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Behaviorally, we provide evidence that positive modulation of KV7.2/7.4 with 
ML213 reduced locomotion at doses of 5.0 and 7.5 mg/kg prior to ethanol exposure, and 
7.5 mg/kg after chronic exposure to ethanol. This suggests two possibilities: (1) the 
previously reported reduction in alcohol seeking and consummatory behaviors may be 
linked to a reduction in locomotion, and (2) ethanol dependence alters the control of motor 
function, allowing for the tolerance to sedation noted at the 5.0 mg/kg dose following CIE 
exposure. As previously noted, alcohol addiction reduces cortical inhibition, allowing the 
emotion and reward centers of the brain to provide more control over the motor control 
systems of the brain. This reduced inhibition may explain some of the recovery in 
locomotor activity following ethanol exposure, although further investigation into this link 
would be needed to confirm this idea. These data also suggest that doses below 5.0 mg/kg 
of ML213 may be viable for testing reductions in alcohol seeking and consummatory 
behaviors in the future as there was no significant reduction in locomotion at those doses 
in mice.  
Using fiber photometry to track and analyze the calcium transients of PL neuron 
populations we find that there was a significant difference in the frequency and amplitude 
of GCaMP6 events observed following ethanol exposure under the effect of ML213 (7.5 
mg/kg). These changes, however, were only found in mice expressing GCaMP6s under 
the hSyn neuron-specific promoter but not in mice expressing GCaMP6f under the CaMKII 
promoter, nor non-dependent mice. With the use of a CaMKII promoter, GCaMP 
fluorescent protein is only expressed in glutamatergic neurons; with a hSyn promoter, 
GCaMP fluoresces in all neuron subtypes found in the region of interest, the PL for these 
studies. As the major neuron subtypes in the PL are composed of glutamatergic pyramidal 
neurons, and parvalbumin- and somatostatin- containing GABAergic interneurons, this 
provides evidence that these changes in neural activity is the result of KV7 channel induced 
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changes on GABAergic interneuron populations. Additionally, the relative similarity in 
inter-event interval, event amplitude, and event frequency among all vehicle treated 
groups prior to and following the induction of ethanol exposure, suggests that all the 
observed significant changes in neuron activity are the result of KV7 channel modulation 
and ethanol exposure together. 
These data taken together indicates that KV7 channels seem to be altered following 
ethanol dependence and allow for the coordination of interneuron activity in the PL. The 
behavioral deficits in locomotor observed prior to CIE exposure are not explained by the 
calcium transients, as they did not differ with the doses of ML213. This suggests that 
positive modulation of KV7 channels may have off-target effects outside of the PL that are 
not accounted for in these studies. One such target is the motor circuit where KV7 positive 
modulation has previously been shown to exhibit strong negative modulatory effects [76, 
101]. The calcium transients, however, do provide insight into how KV7 channels may be 
modulated on interneuron populations. Although our data on KV7.2 expression was not 
conclusive, additional examination into surface level trafficking and additional neuron and 
KV7 channel subtypes is needed to make a conclusive argument on whether KV7 channel 
expression drives the functional changes that were observed in our studies. 
Future Directions 
 As alluded to previously, measuring the expression of other KV7 channel subtypes 
in the PL following ethanol dependence would provide insight into how the expression of 
these channels is altered. Additionally, checking the expression of these various KV7 
channel subtypes on more neuron subtypes found in the PL would help illuminate which 
neurons and KV7 channel subtypes may be good targets for study in the treatment of AUD. 
One major subtype to target in the future are KV7.5 channels, as previous studies in BXD 
mice have demonstrated a negative correlation between Kcnq5 transcript expression and 
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voluntary alcohol consumption [53]. These KV7.5 channels are also a potential target of 
ML213 modulation, although at a lower binding efficiency than KV7.2/7.4.  
Although we assumed that our hSyn promoter primarily indicated the fluorescence 
of glutamatergic pyramidal neurons and PV+/SST+ interneurons, there are other less 
commonly found neuron subtypes in the PL that may have also affected our data. These 
neurons, although vastly outnumbered by the previously mentioned neuron types, are not 
negligible in number in the PL [49]. In addition to the additional immunostaining with 
various subtypes of KV7 channel and neuron subtypes, utilizing assays to test surface 
level expression of KV7 channels may provide better evidence to changes on the various 
neuron subtypes. This would also be a clearer indication of changes in protein trafficking 
that may occur following ethanol dependence. To validate functional changes resulting 
from ethanol dependence, electrophysiological studies are vital. 
 As KV7 channels on PV+ interneurons are still a possible major target for the 
changes observed following ethanol dependence, performing fiber photometry studies 
with PV-CRE transgenic mice will provide direct evidence as to whether these observed 
behavioral changes are the result of functional changes on PV+ interneurons. Using fiber 
photometry, performing additional studies to match drinking or other behavioral 
phenotypes with calcium transients will elucidate some of the mystery behind how AUD 
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